Center-Authored Papers

Filters: Author is Gass, Margery  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
Zhao S, Chlebowski RT, Anderson GL, Kuller LH, Manson JE, Gass M, Patterson R, Rohan TE, Lane DS, Beresford SAA et al..  2014.  Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.. Breast cancer research : BCR. 16(2):R30. Abstract
W
Washington DL, Bird CE, Lamonte MJ, Goldstein KM, Rillamas-Sun E, Stefanick ML, Woods NF, Bastian LA, Gass M, Weitlauf JC.  2016.  Military Generation and Its Relationship to Mortality in Women Veterans in the Women's Health Initiative.. The Gerontologist. 56 Suppl 1:S126-37. Abstract
R
Rillamas-Sun E, LaCroix AZ, Waring ME, Kroenke CH, Lamonte MJ, Vitolins MZ, Seguin R, Bell CL, Gass M, Manini TM et al..  2014.  Obesity and late-age survival without major disease or disability in older women.. JAMA internal medicine. 174(1):98-106. Abstract
M
Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ et al..  2013.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.. JAMA : the journal of the American Medical Association. 310(13):1353-68. Abstract
H
Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SAA, Brzyski R, Chlebowski RT, Gass M, LaCroix AZ, Manson JE et al..  2008.  Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.. JAMA : the journal of the American Medical Association. 299(9):1036-45. Abstract
D
Drieling RL, LaCroix AZ, Beresford SAA, Boudreau DM, Kooperberg C, Chlebowski RT, Gass M, Crandall CJ, Womack CR, Heckbert SR.  2016.  Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.. Menopause (New York, N.Y.). 23(11):1168-1175. Abstract
C
Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B et al..  2015.  Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).. Cancer causes & control : CCC. 26(2):287-96. Abstract
Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE et al..  2009.  Breast cancer after use of estrogen plus progestin in postmenopausal women.. The New England journal of medicine. 360(6):573-87. Abstract
Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE et al..  2010.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.. JAMA : the journal of the American Medical Association. 304(15):1684-92. Abstract
Chlebowski RT, Wakelee H, Pettinger M, Rohan T, Liu J, Simon M, Tindle H, Messina C, Johnson K, Schwartz A et al..  2015.  Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial.. Clinical lung cancer. Abstract
Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, Rodabough RJ, Johnson KC, Wactawski-Wende J, Kotchen JM et al..  2010.  Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.. Journal of the National Cancer Institute. 102(18):1413-21. Abstract
Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M et al..  2009.  Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.. Lancet. 374(9697):1243-51. Abstract
Carbone LD, Johnson KC, Robbins J, Larson JC, Curb DJ, Watson K, Gass M, LaCroix AZ.  2010.  Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI).. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 25(4):873-81. Abstract
B
Brunner RL, Aragaki A, Barnabei V, Cochrane BB, Gass M, Hendrix S, Lane D, Ockene J, Woods NF, Yasmeen S et al..  2010.  Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.. Menopause (New York, N.Y.). 17(5):946-54. Abstract
A
Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell AF, Lane D et al..  2012.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.. The lancet oncology. 13(5):476-486. Abstract
Allison MA, Manson JE, Aragaki A, Langer RD, Rossouw J, Curb D, Martin LW, Phillips L, Stefanick ML, Cochrane BB et al..  2010.  Vasomotor symptoms and coronary artery calcium in postmenopausal women.. Menopause (New York, N.Y.). 17(6):1136-45. Abstract